Trial Profile
Safety and Efficacy of Linagliptin Therapy in the Setting of Internal Medicine Department Type 2 Diabetes Mellitus
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 06 Sep 2017 Planned End Date changed from 1 May 2019 to 1 Nov 2019.
- 06 Sep 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Nov 2018.
- 06 Sep 2017 Planned initiation date changed from 1 Feb 2017 to 1 Oct 2017.